A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Imiquimod (Primary)
- Indications Extramammary Paget disease
- Focus Therapeutic Use
- 29 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 29 Mar 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 22 Apr 2016 Results (n=8) published in the Gynecologic Oncology.